Search for " " - 2/484

Results for “ ”

Entry	Author	Date	Location
Acorda Cuts Staff 25% and Restructures to Keep Focus on Parkinson’s Drug	Frank Vinluan	10/24/19	New York
Xconomy Awards Boston 2019 Honors Best in Life Sciences: Slideshow	Jeff Bauter Engel	10/23/19	Boston
Biogen Reverses Course on Alzheimer’s Drug Analysis, Plans FDA Filing	Sarah de Crescenzo	10/22/19	Boston
Vertex Stock Up on Quick FDA OK For 3-Drug Cystic Fibrosis Therapy	Sarah de Crescenzo	10/22/19	Boston
SeaGen to Seek FDA Nod After Breast Cancer Drug Hits Goals of Key Study	Sarah de Crescenzo	10/21/19	Seattle
Backed by $50M, Verseau Launches to Reprogram Immune Cells Against Cancer	Frank Vinluan	10/21/19	Boston
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More	Frank Vinluan	10/18/19	National
Plexium Debuts With $28M and a New Take on Protein Degradation Drugs	Sarah de Crescenzo	10/17/19	San Diego
Healx Bags $56M to Advance Affordable, AI-Based Orphan Drugs	Mike Ward	10/17/19	National
Nuance & Microsoft Team Up on Conversational AI for Doctors’ Offices	Jeff Bauter Engel	10/17/19	Boston
ArsenalBio Launches With $85M for “Programmable” T Cell Therapies	Frank Vinluan	10/17/19	San Francisco
Eli Lilly Drug Acquired in Armo Deal Fails Pancreatic Cancer Test	Frank Vinluan	10/16/19	Indiana
Alexion to Buy Achillion in $930M Marriage of Rare Disease Drug Firms	Frank Vinluan	10/16/19	Boston
Led by Gilead Veteran Riva, Glenmark’s Ichnos Steps Out on Its Own	Sarah de Crescenzo	10/15/19	New York
Cyteir Adds $40M for Clinical Test of “Synthetically Lethal” Cancer Drug	Frank Vinluan	10/15/19	Boston
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades	Frank Vinluan	10/11/19	Indiana
Vir Bio’s IPO Brings In $143M for Tests of Hepatitis B Drug and More	Frank Vinluan	10/11/19	San Francisco
Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More	Alex Lash	10/11/19	National
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma	Frank Vinluan	10/10/19	Boston
The Placebo Effect Is Hobbling New Psychiatric Drugs. What Can Stop It?	Alex Lash	10/10/19	National
WI Watchlist: Epic, Shine, Venture Investors, Stratatech & More	Jeff Bauter Engel	10/09/19	Wisconsin
Five Years After Y Combinator First Admits Biotechs, They’re Dug In	Bernadette Tansey	10/09/19	San Francisco
Pharma, Biotech VC Investments Continue Shift to Early Stage Deals	Sarah de Crescenzo	10/09/19	National
LabFellows Looks to Become “Operating System” For Life Sciences Cos.	Sarah de Crescenzo	10/08/19	San Diego
Catch Duchenne Patient Power, Phil Sharp & More Next Week at The Broad	Ben Fidler	10/08/19	Boston
With $65M, Cygnal Tunes In to Nerve Signals for Drug-Making Clues	Frank Vinluan	10/08/19	Boston
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels	Frank Vinluan	10/07/19	National
Akcea, Fresh Off C-Suite Shakeup, Dishes Heart Drug to Pfizer for $250M	Ben Fidler	10/07/19	Boston
Precision IBD Rebrands as Prometheus and Strikes R&D Deal With Takeda	Sarah de Crescenzo	10/07/19	San Diego
Unpack Digital Health’s Progress & Pitfalls at X·CON on Oct. 22	Jeff Bauter Engel	10/07/19	Boston
Page 2 of 379	« previous page · next page »